Search

Search Results

• 

  In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression, a marker of platelet activation

  A. Bontadi, A. Ruffatti, S Giannini, E. Falcinelli, M. Tonello, A. Hoxha, P. Gresele, L. Punzi

  35-39

  19-03-2012

  Published: 19 March 2012

  1321

  PDF: 623
• 

  The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus

  M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani

  137-143

  16-12-2016

  Published: 16 December 2016

  1952

  PDF: 1244

• Cryptogenic stroke and seronegative antiphospholipid syndrome: a case series of patients with positivity for “non-criteria” antiphospholipid antibodies

  S. Mancuso, M. De Michele, S. Truglia, A. Capozzi, L. Rapino, I. Berto, C. Alessandri, D. Toni, V. Manganelli, M. Sorice, F. Conti

  25-09-2024

  Published: 25 September 2024

  476

  PDF: 95
• 

  Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

  C. Nalli, L. Andreoli, M. Motta, G.L. Norman, Z. Shums, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, A. Meini, V. Medeghini, T. Avcin, P.L. Meroni, A. Tincani

  91-96

  Published:

  1066

  PDF: 700

• Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome

  S. Olivieri, A. Ruffatti, A. Bontadi, A. Cavazzana, E. Salvan, S. Cuffaro, S. Giunco, L. Punzi

  107-112

  Published:

  1181

  PDF: 678

• Subpopulations of anti-β2glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β2glycoprotein I

  L. Andreoli, C. Nalli, M. Motta, G.L. Norman, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, T. Avcin, P.L. Meroni, A. Tincani

  189-194

  Published:

  1011

  PDF: 590

• Sensibility and specificity for pregnancy morbidity of anti-b2-glycoprotein I antibodies in antiphospholipid syndrome

  M. Tonello, A. Ruffatti, M. Favaro, T. Del Ross, D. Zamboni, P. Grypiotis, A. Cavazzana, M. Ciprian, S. Todesco

  262-266

  Published:

  1051

  PDF: 1003

• Primary antiphosholipid syndrome and hyperomocysteinemia: a study of a group of 29 patients

  T. Del Ross, A. Ruffatti, M. Tonello, G. Salmistraro, A. Calligaro, M. Favaro, M. Ciprian, S. Todesco

  283-287

  Published:

  871

  PDF: 1053
• 

  Adrenal hemorrhage and non-ST elevation myocardial infarction: an antiphospholipid syndrome dilemma

  G. El Hasbani, M. Del Pilar Morel, B. Tandoh, J.F. Vargas, R. Crusio

  18-09-2023

  Published: 18 September 2023

  988

  PDF: 427

• Role of anti-prothrombin in antiphospholipid syndrome

  M. Cinquini, M. Vianelli, F. Allegri, R. Cattaneo, G. Balestrieri, A. Tincani

  243-250

  Published:

  770

  PDF: 1289
• 

  The history of antiphospholipid syndrome

  A. Tincani, G. Fontana, C. Mackworth-Young

  21-03-2023

  Published: 21 March 2023

  1792

  PDF: 1338

• Confirmation of antiphospholipid antibody positivity: a year’s results in a cohort of 113 patients

  S. Cuffaro, T. Del Ross, M. Tonello, A. Bontadi, S. Olivieri, E. Salvan, A. Ruffatti, L. Punzi

  51-59

  Published:

  1347

  PDF: 737

• Laboratory diagnosis of antiphospholipid syndrome

  V. Pengo, A. Ruffatti

  187-191

  Published:

  774

  PDF: 737
• 

  Biclonal gammopathy of undetermined significance in a patient with systemic lupus erythematosus and antiphospholipid syndrome

  V. Bruzzese, P. Scolieri, J. Pepe

  07-02-2022

  Published: 7 February 2022

  5579

  PDF: 564